Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07945431
PHASE2

A Study Evaluating the Efficacy and Safety of Novel Non-Opioid SRP-001 in Acute Pain After Molar Extraction

Sponsor: South Rampart Pharma, Inc.

View on ClinicalTrials.gov

Summary

This study tests whether a single oral dose of SRP-001 (2,000 mg), a non-opioid drug, relieves moderate-to-severe pain after surgery to remove impacted third molars (wisdom teeth), compared with placebo. It also evaluates safety and how the body processes the drug.

Official title: A Phase 2 Randomized, Double-blind, Placebo-controlled Study Assessing Analgesic Efficacy and Safety of the Novel Non-opioid SRP-001 Compared to Placebo in Patients With Moderate-to-severe Acute Postoperative Pain After Impacted Third Mandibular Molar Extraction

Key Details

Gender

All

Age Range

18 Years - 50 Years

Study Type

INTERVENTIONAL

Enrollment

130

Start Date

2026-11-30

Completion Date

2027-02-28

Last Updated

2026-11-18

Healthy Volunteers

No

Interventions

DRUG

SRP-001

SRP-001 Oral Suspension

DRUG

Matching Placebo for SRP-001

Matching Placebo for SRP-001 Oral Suspension

Locations (1)

CenExel JBR Clinical Research

Salt Lake City, Utah, United States